Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Salvator, L. J. Couderc, N. Mahlaoui, E. Rivaud, C. Tcherakian, O. Hermine, F. Suarez, O. Lortholary, E. Catherinot (Suresnes, Paris, France). Pulmonary manifestations in adult patients with chronic granulomatous disease. Eur Respir J 2013; 42: Suppl. 57, 1801

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015 Childhood pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Inflammatory gene polymorphisms in asthma and chronic obstructive pulmonary disease in Venezuela Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Pulmonary manifestation of chronic granulomatous disease (CGD) Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Pulmonary manifestations in patients with IgG4-related disease at a tertiary care institute Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Erdheim-Chester disease: Patterns and pulmonary involvement Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Pulmonary involvement in children with rheumatic diseases Source: International Congress 2016 – Connective tissue disorders Year: 2016 Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Case presentation: Should we always treat IgG4-related lung disease? Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Etiology and evolution of bronchiectasis in men Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Hughes-Stovin syndrome: A case report Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014